Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

102 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Inhibition of CDK8/19 Mediator kinase potentiates HER2-targeting drugs and bypasses resistance to these agents in vitro and in vivo.
Ding X, Sharko AC, McDermott MSJ, Schools GP, Chumanevich A, Ji H, Li J, Zhang L, Mack ZT, Sikirzhytski V, Shtutman M, Ivers L, O'Donovan N, Crown J, Győrffy B, Chen M, Roninson IB, Broude EV. Ding X, et al. Among authors: o donovan n. Proc Natl Acad Sci U S A. 2022 Aug 9;119(32):e2201073119. doi: 10.1073/pnas.2201073119. Epub 2022 Aug 1. Proc Natl Acad Sci U S A. 2022. PMID: 35914167 Free PMC article.
Caspase 3 in breast cancer.
O'Donovan N, Crown J, Stunell H, Hill AD, McDermott E, O'Higgins N, Duffy MJ. O'Donovan N, et al. Clin Cancer Res. 2003 Feb;9(2):738-42. Clin Cancer Res. 2003. PMID: 12576443
EGFR and HER-2 antagonists in breast cancer.
O'Donovan N, Crown J. O'Donovan N, et al. Anticancer Res. 2007 May-Jun;27(3A):1285-94. Anticancer Res. 2007. PMID: 17593621 Free article. Review.
HER-2 signaling and inhibition in breast cancer.
Browne BC, O'Brien N, Duffy MJ, Crown J, O'Donovan N. Browne BC, et al. Curr Cancer Drug Targets. 2009 May;9(3):419-38. doi: 10.2174/156800909788166484. Curr Cancer Drug Targets. 2009. PMID: 19442060 Review.
102 results